Research shows that hormone therapy for prostate cancer may lead to problems with short-term memory, language, thinking, and concentration. But these problems are usually mild. Researchers are still studying the effect of hormone therapy on the brain. When you stop taking hormone therapy, emotional...
Hormone therapy for prostate cancer is also known as androgen deprivation therapy (ADT). cannot grow or survive without , which include and other male hormones. Hormone therapy decreases the amount of androgens in a man's body. Reducing androgens can slow the growth of the cancer and even ...
In 85% to 90% of cases of advanced prostate cancer, hormone therapy can shrink the tumor. However, hormone therapy for prostate cancer doesn't work forever. The problem is that not all cancer cells need hormones to grow. Over time, these cells that aren't reliant on hormones will spread...
If you or a loved one have been diagnosed with prostate cancer, you may be offered hormone therapy to treat it. Increasingly, hormone therapy is the treatment of choice, rather than surgery. Surgery to reduce hormone levels may only be offered if the cancer has spread to other areas or is...
(HealthDay)—Hormone therapy for prostate cancer might dramatically increase a man's risk of developing Alzheimer's disease, a large-scale analysis of health data suggests.
Men on hormone therapy for prostate cancer may benefit significantly from hitting the gym with fellow patients and choosing more veggies and fewer cheeseburgers, a new study suggests. Androgen deprivation therapy is a powerful tool against prostatecancer, and more and more men are opting for the ...
Efficacy of primary hormone therapy for localized or locally advanced prostate cancer: results of a 10-year follow-up. OBJECTIVE: To evaluate the efficacy of primary hormone therapy for localized or locally advanced prostate cancer, by analysing the 10-year survival rates f... H Akaza,Y Homma,...
Prostate cancer patients who receive hormone treatments before undergoing three-dimensional conformal radiation therapy (3D-CRT) do not have increased side effects compared with those not receiving hormone therapy before radiation, according to a new study in the International Journal of Radiation Oncology...
Future Prospects for Luteinizing Hormone-Releasing Hormone Analogues in Prostate Cancer Treatment Luteinizing hormone-releasing hormone (LHRH) analogues play a pivotal role in hormonal therapy regimens for the treatment of prostate cancer. Hormonal ther... H Akaza - 《Pharmacology》 被引量: 40发表: ...
We report an unusual case of bilateral, synchronous breast cancer in a male patient who had a history of estrogen therapy for prostate cancer. A 64-year-old Japanese man was diagnosed with T1N0M0 prostate cancer and received a total prostatectomy. Twenty months after the resection, the patient...